Merck KgaA 2020 Earnings, Sales Rise; Increases Dividend
March 04 2021 - 2:03AM
Dow Jones News
By Cecilia Butini
Merck KgaA said Thursday that its earnings and sales rose in
2020 despite the coronavirus pandemic, and increased its proposed
dividend.
The German pharmaceuticals-and-chemicals company posted aftertax
profit of 1.99 billion euros ($2.40 billion), up from EUR1.32
billion in 2019.
The closely watched company metric "Ebitda pre"--earnings before
interest, taxes, depreciation and amortization before one-time
items--came in at EUR5.20 billion, compared with EUR4.39 billion,
Merck said.
Net sales were EUR17.53 billion, up from EUR16.15 billion.
The company proposed a dividend for 2020 of EUR1.40 a share, up
EUR0.10 from the previous year. It also said that it would rename
its performance-materials business as electronics effective
immediately.
Merck said it expects strong organic sales growth in 2021, and
projects organic Ebitda pre growth in the percentage range of high
single digits to low teens.
In the medium term, the company said it continues to guide for
around EUR2 billion in sales from new products in 2022.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
March 04, 2021 01:48 ET (06:48 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Apr 2023 to Apr 2024